e-learning
resources
Berlin 2001
Sunday 23.09.2001
Lung cancer diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Contribution of immunological examination to the diagnosis of lung cancer
D. Petrášová, M. FriČovská, J. Štubňa, E. Hijová, J. KoproviČová (Košice, Slovakia)
Source:
Annual Congress 2001 - Lung cancer diagnosis
Session:
Lung cancer diagnosis
Session type:
Thematic Poster Session
Number:
512
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Petrášová, M. FriČovská, J. Štubňa, E. Hijová, J. KoproviČová (Košice, Slovakia). Contribution of immunological examination to the diagnosis of lung cancer. Eur Respir J 2001; 16: Suppl. 31, 512
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Cytological diagnostics of lung cancer: our experience
Source: Eur Respir J 2005; 26: Suppl. 49, 306s
Year: 2005
Evaluation of the role of bronchoscopy in the diagnosis of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006
Early diagnosis of peripheral lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 319s
Year: 2005
Role of the control radiological examination in active detection of TB and lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 423s
Year: 2005
The diagnostic relevance of cytologic examination of induced sputum in lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 299s
Year: 2004
Role of CT guided lung biopsy in the diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 65s
Year: 2001
Screening and diagnosis of lung cancer
Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer
Year: 2013
Use of endosonography for diagnosis and staging of lung cancer and assessment of sarcoidosis
Source: International Congress 2019 – PG9 Interventional pulmonology
Year: 2019
Bronchoscopic techniques in diagnosis and staging of lung cancer
Source: Breathe 2011; 7: 324-337
Year: 2011
The role of bronchoscopy in the diagnosis of lung cancer and other diseases
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Possibility of noninvasive differential diagnostics of lung tuberculosis and lung cancer in oncologic hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 160s
Year: 2003
Evaluation of the efficacy of bronchial endoscopy in the diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 60s
Year: 2001
The role of molecular pathology in diagnosis and treatment of lung cancer
Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases
Year: 2007
Feasibility study of cryobiopsy for practical pathological diagnosis including immunohistochemical assessment of primary lung cancer
Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment
Year: 2018
Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Lung function testing for the preoperative evaluation of patients with lung cancer
Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept